Biotech Values

[DewDiligence]

POZN reverse merges with TBUFF; merged company renamed Aralez with tax domicile in Ireland:

http://finance.yahoo.com/news/pozen-announces-strategic-acquisition-tribute-144500688.html

At closing, each share of POZEN common stock will be converted into the right to receive one Aralez ordinary share and each common share of Tribute (other than dissenting shares) will be exchanged for 0.1455 Aralez ordinary shares. As a result of the proposed transaction and before giving effect to the contemplated financing, stockholders of POZEN will own approximately 66 percent of Aralez and shareholders of Tribute would own approximately 34 percent of Aralez…

…Upon closing, Aralez is expected to trade on NASDAQ and TSX.

Adrian Adams, the current CEO of Pozen, will become the CEO of Aralez.

Note that one of the QLTI investing transactions announced today in #msg-114403679 pertains to Aralez.